Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T92494 | Target Info | |||
Target Name | Eukaryotic elongation factor 2 kinase (eEF-2K) | ||||
Synonyms |
eEF-2K; eEF-2 kinase; Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | EEF2K | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Epidermal growth factor receptor (EGFR) | Successful Target | ||||
UniProt ID | EGFR_HUMAN | |||||
Gene Name | EGFR | |||||
Synonyms |
Receptor tyrosine-protein kinase erbB-1; Proto-oncogene c-ErbB-1; HER1; ERBB1; ERBB
Click to Show/Hide
|
|||||
Representative Drug(s) | Lapatinib | Drug Info | IC50 = 1.8 nM | [1] | ||
Co-Target Name | Erbb2 tyrosine kinase receptor (HER2) | Successful Target | ||||
UniProt ID | ERBB2_HUMAN | |||||
Gene Name | ERBB2 | |||||
Synonyms |
p185erbB2; Tyrosine kinase-type cell surface receptor HER2; Receptor tyrosine-protein kinase erbB-2; Proto-oncogene c-ErbB-2; Proto-oncogene Neu; NGL; NEU; Metastatic lymph node gene 19 protein; MLN19; MLN 19; HER2; CD340
Click to Show/Hide
|
|||||
Representative Drug(s) | Lapatinib | Drug Info | IC50 = 2.7 nM | [2] | ||
Co-Target Name | Fyn tyrosine protein kinase (FYN) | Successful Target | ||||
UniProt ID | FYN_HUMAN | |||||
Gene Name | FYN | |||||
Synonyms |
Tyrosine-protein kinase Fyn; Src-like kinase; SLK; Proto-oncogene tyrosine-protein kinase Fyn; Proto-oncogene c-Fyn; Proto-oncogene Syn; Fyn p59-Fyn; Fyn Protooncogene Syn
Click to Show/Hide
|
|||||
Representative Drug(s) | Lapatinib | Drug Info | Ki ~ 398.11 nM | [3] | ||
Co-Target Name | Tyrosine-protein kinase ABL1 (ABL) | Successful Target | ||||
UniProt ID | ABL1_HUMAN | |||||
Gene Name | ABL1 | |||||
Synonyms |
p150; Proto-oncogene tyrosine-protein kinase ABL1; Proto-oncogene c-Abl; JTK7; C-ABL; Abl; Abelson tyrosine-protein kinase 1; Abelson murine leukemia viral oncogene homolog 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Lapatinib | Drug Info | Ki ~ 630.96 nM | [3] | ||
Co-Target Name | Proto-oncogene c-Src (SRC) | Successful Target | ||||
UniProt ID | SRC_HUMAN | |||||
Gene Name | SRC | |||||
Synonyms |
pp60c-src; Tyrosine kinase (pp60(src)); Src tyrosine kinase; SRC1; Proto-oncogene tyrosine-protein kinase Src; Pp60(src); P60-Src; C-src TK; C-Src
Click to Show/Hide
|
|||||
Representative Drug(s) | Lapatinib | Drug Info | Ki ~ 630.96 nM | [3] | ||
Co-Target Name | Erbb4 tyrosine kinase receptor (Erbb-4) | Successful Target | ||||
UniProt ID | ERBB4_HUMAN | |||||
Gene Name | ERBB4 | |||||
Synonyms |
Tyrosine kinase-type cell surface receptor HER4; Receptor tyrosine-protein kinase erbB-4; Proto-oncogene-like protein c-ErbB-4; P180erbB4; HER4
Click to Show/Hide
|
|||||
Representative Drug(s) | Lapatinib | Drug Info | IC50 ~ 1000 nM | [4] | ||
Co-Target Name | Insulin-like growth factor I receptor (IGF1R) | Successful Target | ||||
UniProt ID | IGF1R_HUMAN | |||||
Gene Name | IGF1R | |||||
Synonyms |
Type 1 insulin-like growth factor receptor; Insulin-like growth factor 1 receptor; IGF-IR; IGF-I receptor; IGF-1R; IGF-1 receptor; CD221 antigen; CD221
Click to Show/Hide
|
|||||
Representative Drug(s) | Lapatinib | Drug Info | Ki ~ 1000 nM | [3] | ||
Co-Target Name | Voltage-gated potassium channel Kv11.1 (KCNH2) | Successful Target | ||||
UniProt ID | KCNH2_HUMAN | |||||
Gene Name | KCNH2 | |||||
Synonyms |
hERG1; hERG-1; Voltage-gated potassium channel subunit Kv11.1; Potassium voltage-gated channel subfamily H member 2; HERG K+ channel; HERG; H-ERG; Ether-a-go-go-related protein 1; Ether-a-go-go-related gene potassium channel 1; Ether-a-go-go related protein 1; Ether-a-go-go related gene potassium channel 1; Eag related protein 1; Eag homolog; ERG-1; ERG
Click to Show/Hide
|
|||||
Representative Drug(s) | Lapatinib | Drug Info | IC50 = 1000 nM | [5] | ||
Co-Target Name | Vascular endothelial growth factor receptor 1 (FLT-1) | Clinical trial Target | ||||
UniProt ID | VGFR1_HUMAN | |||||
Gene Name | FLT1 | |||||
Synonyms |
Vascular permeability factor receptor; VEGFR1; VEGFR-1; VEGF-1 receptor; Tyrosine-protein kinase receptor FLT; Tyrosine-protein kinase FRT; Fms-like tyrosine kinase 1; FRT; FLT
Click to Show/Hide
|
|||||
Representative Drug(s) | Lapatinib | Drug Info | Ki ~ 398.11 nM | [3] | ||
Co-Target Name | Erbb3 tyrosine kinase receptor (Erbb-3) | Clinical trial Target | ||||
UniProt ID | ERBB3_HUMAN | |||||
Gene Name | ERBB3 | |||||
Synonyms |
Tyrosine kinase-type cell surface receptor HER3; Receptor tyrosine-protein kinase erbB-3; Proto-oncogene-like protein c-ErbB-3; HER3; C-erbB3; C-erbB-3 protein
Click to Show/Hide
|
|||||
Representative Drug(s) | Lapatinib | Drug Info | IC50 ~ 1000 nM | [4] | ||
Co-Target Name | B lymphocyte kinase (BLK) | Patented-recorded Target | ||||
UniProt ID | BLK_HUMAN | |||||
Gene Name | BLK | |||||
Synonyms |
p55-Blk; Tyrosine-protein kinase Blk
Click to Show/Hide
|
|||||
Representative Drug(s) | Lapatinib | Drug Info | Ki ~ 794.33 nM | [3] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Lead generation of 1,2-dithiolanes as exon 19 and exon 21 mutant EGFR tyrosine kinase inhibitors. Bioorg Med Chem Lett. 2019 Jun 15;29(12):1435-1439. | ||||
REF 2 | Design and synthesis of Lapatinib derivatives containing a branched side chain as HER1/HER2 targeting antitumor drug candidates. Eur J Med Chem. 2014 Nov 24;87:631-42. | ||||
REF 3 | PubChem BioAssay: 2017 update. Nucleic Acids Res. 2017 Jan 4;45(D1):D955-D963. | ||||
REF 4 | Synthesis and biological evaluation of pyrimidine-based dual inhibitors of human epidermal growth factor receptor 1 (HER-1) and HER-2 tyrosine kinases. J Med Chem. 2012 Mar 22;55(6):2846-57. | ||||
REF 5 | Prediction of Thorough QT study results using action potential simulations based on ion channel screens. J Pharmacol Toxicol Methods. Nov-Dec 2014;70(3):246-54. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.